Patent Assignment
Reel/Frame 023993/0447
Change of Name
Recorded: 2010-02-25
Received: 2010-02-25
Pages: 4
Assignor
NASTECH PHARMACEUTICAL COMPANY, INC.
Executed: 2008-06-10
Assignee
MDRNA, INC.
3830 MONTE VILLA PARKWAY, BOTHELL, WA, 98021, UNITED STATES
Covered Properties
(6)
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Application:
12/445,868 →
Methods and Compositions for Enhancing Delivery of Double-Stranded Rna or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression in Mammalian Cells
Application:
12/013,274 →
Rnai Therapeutic for Respiratory Virus Infection
Application:
11/910,971 →
Method of Treating an Inflammatory Disease by Double Stranded Ribonucleic Acid
Application:
11/576,139 →
Dry Powder Compositions for Rna Influenza Therapeutics
Application:
11/623,306 →
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
Application:
11/223,699 →